Learn More
Description
In blood, cholesterol and triglycerides are transported in lipoprotein particles that consist of a single layer of phospholipid surrounding a lipid core and surface-associated apolipoproteins (Apo). The Apo-proteins are involved in the specific binding of cellular receptors, the regulation of lipolytic enzymes, and the process of lipid exchange. High density lipoprotein particles (HDLs) contain the apolipoproteins ApoA-I, ApoA-II and Apo-M, whereas low density (LDL), intermediate density, and very low density (VLDL) lipoprotein particles contain ApoB-100 as the primary structural element. ApoA-I is synthesized in the liver and small intestines, where it acts as a cofactor for lecithin-cholesterol acyltransferase during the formation of cholesterol ester. ApoA-II is synthesized in the liver where it activates hepatic lipase. In HepG2 cells, treatment with gramoxone causes oxidative stress and reductions in ApoA-I mRNA levels. This down regulation of ApoA-I may contribute to reduced plasma HDL levels in response to oxidants, such as cigarette smoke. Thus, ApoA-I is an important cofactor fo cholesterol synthesis and is a major component of HDLs.
Western Blotting
Specifications
Specifications
| Antigen | ApoA-1 |
| Applications | Western Blot |
| Classification | Monoclonal |
| Clone | 4 |
| Concentration | 250μg/mL |
| Conjugate | Unconjugated |
| Host Species | Mouse |
| Immunogen | Rat ApoA-I aa. 144-258 |
| Purification Method | Affinity Purified |
| Quantity | 50 μg |
| Show More |
For Research Use Only.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.